Titlebook: Hughes Syndrome; Antiphospholipid Syn M. A. Khamashta (Deputy Head) Book 2006Latest edition Springer-Verlag London 2006 Antiphospholipid Sy

我在争斗志

书目名称Hughes Syndrome影响因子(影响力)




书目名称Hughes Syndrome影响因子(影响力)学科排名




书目名称Hughes Syndrome网络公开度




书目名称Hughes Syndrome网络公开度学科排名




书目名称Hughes Syndrome被引频次




书目名称Hughes Syndrome被引频次学科排名




书目名称Hughes Syndrome年度引用




书目名称Hughes Syndrome年度引用学科排名




书目名称Hughes Syndrome读者反馈




书目名称Hughes Syndrome读者反馈学科排名

凶兆

Primary Antiphospholipid Syndromee absence of other co-morbid conditions such as SLE. Advances in our understanding of the pathogenesis of PAPS should facilitate the development of improved treatment and outlook for patients with all forms of the APS.

无聊的人

Cardiac Manifestations in Antiphospholipid Syndrome antibodies in cardiac diseases. Until these studies become available, clinicians should consider a search for aPL in those patients with the previously reported cardiac complications in whom no other etiology could be found.

Water-Brash

d Syndrome addresses the complete range of conditions produced by this common disorder which is also known as APS or "sticky blood" syndrome. APS is one of the main causes of strokes (40%), leg deep vein thrombosis, and recurrent miscarriages in women. It is an important risk factor for thrombosis i

countenance

Osteoarticular Manifestations of Antiphospholipid Syndromeents with persistent symptoms originating from sites most susceptible to osteonecrosis should undergo MRI evaluation. A systematic screening for aPL in all cases with diagnosed osteonecrosis in the absence of precipitating factors should also be considered.

ordain

Catastrophic Antiphospholipid Syndromecirculating cellular inflammatory cells, elements of the phospholipid-dependent coagulation factors, and platelets in the presence of aPL. Improved therapy awaits better understanding of the underlying immunologic, coagulation, and vascular pathology.

宿醉

议程

盘旋

Skin Manifestations of Antiphospholipid Syndromekin involvement might be the first manifestation of APS (41%) and over one third of these patients will develop multisystem thrombotic events during the course of the disease. Therefore, a close monitoring of these patients is warranted.

Amorous